raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:98896

Duchenne muscular dystrophy

Synonyms: DMD · Severe dystrophinopathy, Duchenne type

Type
Disease
Group
Disorder
Inheritance
X-linked recessive
Age of onset
Childhood
Status
active

A rare, genetic, muscular dystrophy characterized by rapidly progressive muscle weakness and wasting due to degeneration of skeletal, smooth and cardiac muscle.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enDuchenne muscular dystrophyDMD · Severe dystrophinopathy, Duchenne type
frDystrophie musculaire de DuchenneDMD · Dystrophinopathie de Duchenne
deMuskeldystrophie Typ DuchenneDMD · Duchenne-Muskeldystrophie · Dystrophinopathie vom Typ Duchenne · Schwere Dystrophinopathie vom Typ Duchenne
esDistrofia muscular de DuchenneDMD · Distrofinopatía grave tipo Duchenne
itDistrofia muscolare di DuchenneDMD · Distrofinopatia grave, tipo Duchenne
nlSpierdystrofie van DuchenneDMD · Ernstige dystrofinopathie, Duchenne-type
ptDistrofia muscular, tipo Duchenne
plDystrofia mięśniowa Duchenne'aCiężka dystrofinopatia, typu Duchenne'a · DMD
csDuchennova muskulární dystrofieDMD · Vážná dystrofinopatie, Duchennův typ
ukМязова дистрофія ДюшенаDMD · Тяжка дистрофінопатія, тип Дюшена
zh杜氏肌营养不良症重型杜氏肌营养不良
trDuchenne kas distrofisiDMD · Ağır distrofinopati, Duchenne tipi

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM310200Evalidated
ICD-10G71.0NTBTinclusionvalidated
ICD-118C70.1Especificvalidated
MONDO0010679Evalidated
MeSHD020388Evalidated
UMLSC0013264Evalidated
GARD6291Evalidated
MedDRA10013801Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (5):

No children.

4

Genes

2 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
DMDDisease-causing germline mutation(s) inAssessedHGNC:2928ENSG00000198947300377Xp21.2-p21.1dystrophin
LTBP4Modifying germline mutation inAssessedHGNC:6717ENSG0000009000660471019q13.2latent transforming growth factor beta binding protein 423440719[PMID]
5

Prevalence and incidence

15 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 100 0009.9 / 100 000WorldwideValue and classValidated32503598[PMID]
Point prevalence1-9 / 100 0004.14 / 100 000United KingdomValue and classValidated19767415[PMID]_24780148[PMID]_ORPHANET
Prevalence at birth1-5 / 10 00014 / 100 000United StatesValue and classValidated12495984[PMID]
Prevalence at birth1-5 / 10 00012 / 100 000NetherlandsValue and classValidated1733827[PMID]
Prevalence at birth1-5 / 10 00010.5 / 100 000CanadaValue and classValidated20080524[PMID]
Prevalence at birth1-9 / 100 0009.7 / 100 000United KingdomValue and classValidated23340516[PMID]
Point prevalence1-9 / 100 0002.59 / 100 000Puerto ricoValue and classValidatedDOI:10.3233/JND-160147[OTHER]
Prevalence at birth1-9 / 100 0008.2 / 100 000IrelandValue and classValidated8845721[PMID]_24780148[PMID]
Point prevalence1-9 / 100 0001.7 / 100 000ItalyValue and classValidated10466417[PMID]_24780148[PMID]
Point prevalence1-9 / 100 0004.26 / 100 000IrelandValue and classValidated8845721[PMID]_24780148[PMID]
Point prevalence1-9 / 100 0002.8 / 100 000WorldwideValue and classValidated32503598[PMID]
Lifetime Prevalence1-9 / 100 0007.66 / 100 000EgyptValue and classValidated16210862[PMID]_24780148[PMID]
Point prevalence1-9 / 100 0003.56 / 100 000JapanValue and classValidated1745328[PMID]_24780148[PMID]_ORPHANET
Point prevalence1-9 / 1 000 0000.47 / 100 000South AfricaValue and classValidated7825085[PMID]_24780148[PMID]_ORPHANET
Point prevalence1-9 / 100 0002.75 / 100 000DenmarkValue and classValidated14678803[PMID]_24780148[PMID]_ORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

15 annotations · validated 2017-07-06
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0008981Calf muscle hypertrophy
HP:0001638Cardiomyopathy
HP:0100543Cognitive impairment
HP:0000750Delayed speech and language development
HP:0003236Elevated circulating creatine kinase concentration
HP:0001371Flexion contracture
HP:0001263Global developmental delay
HP:0001270Motor delay
HP:0003323Progressive muscle weakness
HP:0003701Proximal muscle weakness
HP:0002093Respiratory insufficiency
HP:0002650Scoliosis
HP:0003202Skeletal muscle atrophy
HP:0001328Specific learning disability
HP:0002515Waddling gait

Run the differential on the 12 obligate / very frequent terms

Annotation source: 27524897[PMID]

7

Sources for this card